1.24 USD
▼-0.07-5.34%
盘后 1.26 0.00%
2026-09-16
市值
$8.71M
市盈率
—
EPS
-1.30
股息率
—
52 周区间
1.05 – 9.48
成交量
16.87K
Beta
3.62
目标价
—
52W 低 1.0552W 高 9.48
价格走势
公司简介
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.